Interdisciplinary Research Stimulating Health Technology Innovation in IMSaT Dr Mike MacDonald IMSaT and Physics University of Dundee 23 April 2010.

Slides:



Advertisements
Similar presentations
Introduction to the unit and mixed methods approaches to research Kerry Hood.
Advertisements

Ioannis Karakitsios, Timur Saliev, Helen McLeod, Sarfraz Ahmad, Andreas Melzer Ioannis Karakitsios, Timur Saliev, Helen McLeod, Sarfraz Ahmad, Andreas.
Alexander Volovick 1, Timur Saliev 2, Sam Eljamel 2, Roos Eisma 2, Andreas Melzer 2 1 Insightec, Israel; 2 Institute for Medical Science & Technology,
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
1 Confidential Science of Stem Cells and Potential Applications Andrea Hunt February 22, 2008.
The Israel Export & International Cooperation Institute Israel’s Medical Devices and Supplies Industry Rising to the Challenge.
The BHRUT Clinical Strategy Presentation for stakeholders, patients and the public.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
Challenges in Clinical Applications for Nanotechnology N. Tony Eissa, MD Table 3.
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
Modelling the impact of service innovation in stroke care Information and Communication Research Initiative 2 (ICTRI 2) Research Seminar 15 February 2007.
RADIOLOGY Technology Trends and Their Impact on American Healthcare Monte Clinton, CRA Director of Radiology Dartmouth-Hitchcock Medical Center Lebanon,
NICE, medtech and evidence Mrs Mirella Marlow MA MBA Programme Director MediWales 11 December 2012.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
The NIH Roadmap for Medical Research
Radiotherapy for Kidney cancer
The NANOPORATION project has received funding from the European Community’s Seventh Framework Programme (FP7/ ) under Grant Agreement no
The Outreach Project “Helping NW companies access fund for R&D” Lesley Lambert General Engineering Research Institute Liverpool John Moores University.
Targeted Gold Nanoparticles as Vascular Disrupting Agents during Radiation Therapy RI Berbeco 1, H Korideck 1, S Kunjachan 1, R Kumar 2, S Sridhar 2, A.
DMD Conference McNamara Alumni Center April 10, 2013 Bin He, Ph.D. Director, Institute for Engineering in Medicine.
Bioengineering, Biotechnology, and Imaging November 19, 2007 NCDD Meeting Chair: Barbara B. Bass, MD Vice Chair: David A. Lieberman, MD.
Institute on Systems Science and Health- Federal Funding Panel Grace C.Y. Peng, Ph.D. May 25, 2011.
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
A stroke is the leading cause of permanent impairment and disability. Pending a radical cure, patients recovering from a stroke will continue to require.
AHRQ’s Role in Comparative Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality Alliance for Health Reform Briefing.
Queen Mary, University of London: Discipline Bridging Initiative 1 Queen Mary, University of London Discipline Bridging Initiative Funded via the MRC/EPSRC.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Overview: FY12 Strategic Communications Plan Meredith Fisher Director, Administration and Communication.
Aberdeen Confidence in Concept Fund Prof Phil Hannaford Vice Principal – Research & Knowledge Exchange.
3D Slicer: A Free & Open Source Platform For Medical Image Analysis and Visualization Brigham and Women’s Hospital.
Funding Opportunities at the NIH and the National Institute of Biomedical Imaging and Bioengineering Grace C.Y. Peng, Ph.D. March 19, st annual ORNL.
Progress in the RNOH-IOMS Joint Academic Strategy David Marsh Professor of Clinical Orthopaedics, Institute of Orthopaedics and Musculoskeletal Science.
Steph Garfield-Birkbeck Assistant Director NIHR Evaluation Trials and Studies Coordinating Centre, University of Southampton.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
RESEARCH AND INNOVATION Mr Ken Lavery, Medical Director.
Field-Induced Magnetic Nanoparticle Drug Delivery BME 273 Group 15 Team Leader : Ashwath Jayagopal (BME, EE, MATH) Members : Sanjay Athavale (BME) and.
Dr Renu Bindra Joint Strategic Needs Assessment. Policy background January 2006 “Strategic Needs Assessment” October 2006 “Joint Strategic Needs Assessment”
6/4/20161 Commitment & Efforts Toward Translational Science Subtitle Placeholder.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH CTSI Funding Opportunities
The HMO Research Network (HMORN) is a well established alliance of 18 research departments in the United States and Israel. Since 1994, the HMORN has conducted.
James Hahn, Ph.D. Director, Institute for Biomedical Engineering Chair, Department of Computer Science George Washington University
PURPOSE The purpose of this work was to commission and to evaluate the role of MR guided high intensity focused ultrasound (MRgHIFU) in cancer therapy.
Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.
Brief Project Overview: Focus: Acoustic and ultrasound education, research, and development with emphases on medical and industrial applications. Goals:
Field-Induced Magnetic Nanoparticle Drug Delivery BME 273 Group 15 Team Leader : Ashwath Jayagopal (BME, EE, MATH) Members : Sanjay Athavale (BME) and.
Topic 3A SEMANTIC INTEROPERABILITY: REUSE OF EHR DATA Mats Sundgren.
FDA’s Public Workshop: Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges Paul Goldfarb, MD, FACS.
R.I.MacDonald President, Canadian Institute for Photonics Innovation Ottawa Centre for Research and Innovation The Partnership Conference Series: The Photonics.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Simon Butler Centre Manager Funding Track record £7.8M.
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
NoWCADD Progress Report 2015
Medical Robotics UH MRI-guided Robotic Interventions and Surgeries This technology was supported by the NSF award CNS entitled “Multimodal.
Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.
Medical and Health research in Norway – in brief Director Mari K. Nes 22 June 2006.
MR-guided Focused Ultrasound Ablation in a Preclinical Thiel Model Ioannis Karakitsios,Xu Xiao, Markus Domschke, Andreas Melzer Institute of Medical Science.
Context for Next Stage of Integration Professor Tony WellsGerry Marr Chief ExecutiveChief Operating OfficerNHS Tayside.
II Volga specialized forum "Medicine. Pharmacy"
The potential of Interventional radiology
NIHR Invention for Innovation (i4i)
The Health Services Research Centre and NAP5
A stroke is the leading cause of permanent impairment and disability
From Bench to Clinical Applications: Money Talks
The potential of Interventional radiology
Welsh Health Innovation Technology Accelerator
World Health Organization
Information Session January 18, :00-1:45 pm
Clinical and Translational Science Awards Program
An Introduction to the NIHR programmes
Patient-Centered Outcomes Research Institute (PCORI)
Presentation transcript:

Interdisciplinary Research Stimulating Health Technology Innovation in IMSaT Dr Mike MacDonald IMSaT and Physics University of Dundee 23 April 2010

Background

IMSaT Institute for Medical Science and Technology (IMSaT) launched in January 2008 by University of Dundee to promote joint activity between medicine, life sciences and the physical sciences and engineering IMSaT Medicine Life Sciences Science and Engineering

IMSaT Institute for Medical Science and Technology (IMSaT) launched in January 2008 by University of Dundee to promote joint activity between medicine, life sciences and the physical sciences and engineering IMSaT Medicine Life Sciences Science and Engineering

Realisation More than £6M investment More than £17M awards since launch Now ~50 staff and students Facilities almost completed IMSaT Ninewells Hospital

Facilities

Cell biology and nanomedicine Interventional MRI Surgical Technology Photonics Ultrasonics Local Laboratories IMSaT Infrastructure

Cell biology and nanomedicine Interventional MRI Surgical Technology Photonics Ultrasonics Local Laboratories IMSaT Infrastructure

Cell biology and nanomedicine Interventional MRI Surgical Technology Photonics Ultrasonics Local Laboratories IMSaT Infrastructure

Staff and Collaborators

IMSaT Research Leaders Prof. Andreas Melzer, Director, specialism in MRI- guided intervention and surgery Prof. Sir Alfred Cuschieri, Chief Scientific Advisor, specialism in minimal access surgery Dr Sandy Cochran, Team Leader in medical ultrasound Dr Stuart Brown, Team Leader in surgical technology Dr Mike MacDonald, Team Leader in biophotonics Dr Paul Prentice, Team Leader in photoacoustics Dr Lijun Wang, Team Leader in cell biology and nanomedicine

Andreas Melzer – pre-clinical Alfred Cuschieri – clinician/scientist Sandy Cochran – engineer / physicist Stuart Brown – mechanical engineer Mike MacDonald – applied physicist Paul Prentice – applied physicist Lijun Wang – life scientist TBC – clinician TBC – life scientist Research Leader Backgrounds

Some Local Collaborators Prof. Alistair Thomson, Surgery and Molecular Oncology, Ninewells Hospital Dr George Corner, Medical Physics/Ultrasound, Ninewells Hospital Dr Elaine Henry, Gastroenterology, Ninewells Hospital Dr Graeme Houston, Oncology, Ninewells Hospital Dr Zhihong Huang, Ultrasound, Dundee University Dr Rob Keatch, Tissue Engineering, Dundee Univ. Dr Graeme MacLeod, Anaesthesia, Ninewells Hospital

Some External Collaborators University of Birmingham, Materials University of Bristol, Mechanical Engineering Fraunhofer IKTS, Materials University of Glasgow, Electronic Engineering Institute for Cancer Research, Medical Physics Insightec (Israel), Focused ultrasound surgery Penn State University, Materials University of Southampton, Engineering Trondheim University, Surgical technology Weidlinger Associates (USA), Design software

Some Previous/Present Collaboration

Strategy and Delivery

Strategic Dimensions Key Target Area Image-guided intervention Applications Oncology, Cardiovascular, and Other (e.g. Anaesthesia, Surgical techniques) Technology MRI, ultrasound, and biophotonic imaging, with state-of-the-art intervention, including surgical technology and devices Collaboration Strong bias towards scientific, engineering and clinical collaboration Clinical application Strong bias towards clinical application of research outcomes

IMSaT’s strategic plan includes a project pipeline for commercialisation of research Commercialisation

Large Projects Nanoporation (£1.8M) – Targeted drug delivery Sonotweezers (£1.5M) – Particle / cell manipulation Lightsheet microscopy (£0.7M) – embryo imaging Biomag (£1.4M) – Surgical manipulation of magnetised tissue Laparoscopy (£2.5M) – New tools for keyhole surgery IIIOS (£3.7M) – Interventional imaging operating system DPFS (£0.6M) - Device / model development

Sample of Other Projects Ultrasonic virtual histology (3 x grad student) Devices for ultrasonic cutting (3 x grad student) Integration of Si and piezoelectrics (1 x postdoc) Ultrasound guided regional anaesthesia (2 x grad student, 1 x undergrad) Laser generated ultrasound (1 x grad student) Photoacoustic imaging (1 x grad student) Optical anastamotic perfusion assessment (1 x ungrad) MRgFUS (4 x grad student) Tissue motion tracking (2 x grad student) Microbubble processing (1 x grad student) Nerve regeneration with magnetic nanoparticles (1 x postdoc) Organ retraction in surgery (1 x postdoc) Ultrasound phantoms (1 x postdoc)

Case Study 1: Ultrasound innovation

UGRA Regional anaesthesia gaining wide acceptance Clinical aim is to introduce anaesthetic locally around nerve to block pain, typically in limb Benefits include long lasting postoperative pain relief, accelerated rehabilitation, improvements in quality of life Potential side effects include convulsions / cardiac arrest from intravascular injection and permanent nerve damage and loss of function from intraneural injection Unmet need is for a specialised ultrasound probe for ultrasound-guided regional anaesthesia (UGRA) Requirements relate to imaging performance and ergonomics

New Imaging Configuration Cable outlet Array casing Needle Position of electroacoustic transducer components Ultrasound beam Cable outlet Needle Array casing Ultrasound beam Position of electro- acoustic transducer components Needle oblique to ultrasound beam from conventional transducer, can’t penetrate spine Needle parallel to ultrasound beam when inserted through alternate transducer design 

Previous Solution Optimised for epidural injection in obese subjects only

Lumbar Spine Image AG – Acoustic gap II – Interspinous interspace SP – Spinous process SP II AG II

Clinical Trial and Future Work Previous clinical trial Transducer safety confirmed, including CE marking More than 50 obese subjects at multiple sites Primary end point: time to insert needle Trial completed; 20% time saving New MRC DPFS funding awarded £250k over 18 months to develop device for more widely used regional nerve blocks Technical issues, ergonomics and IP all important

Case Study: MRgFUS

MRgFUS: MRI-guided Focused Ultrasound Surgery Risks of surgical therapy outweigh potential benefits for many patients E.g. frail, elderly patients and patients with benign tumours Non-invasive focused ultrasound surgery is a possibility Image guidance is crucial

Simple Ultrasonic Hyperthermia Custom transducer for high intensity focused ultrasound (HIFU) Hyperthermia applied to poultry breast in vitro, max. intensity 240 W cm -2

Illustrative Results Visual Histology HFUS SEM

Illustrative Results Visual Histology HFUS SEM Necrosed tissue Viable tissue

Image Guidance MRI presently the leading image guidance technique MRgFUS - MRI- guided focused ultrasound surgery Ultrasound guidance also possible

MRgFUS Thiel cadaver with InSightec Exablate 2000 system

Matrix Array Transducer Preliminary trials of hyperthermic necrosis of cadaveric liver

Robot-mounted Matrix Array Demonstration of possible future of image-guided surgery

Summary and the Future

IMSaT and its partners now allow seamless translation of basic research into clinical progress Imaging is a key topic in Dundee Many projects now under way Case study: MR-guided focused ultrasound surgery Great potential; many major companies and universities engaged in clinical studies Summary

Next Steps Stronger theming Less opportunistic funding, stronger focus on strategy Commercialisation Recruitment of business liaison person Enhanced marketing/sales Revised website, planned exhibition and conference attendance ISO13485/GLP Certification To reduce barriers to clinical adoption Additional facilities Establishment of full preclinical resource unit